Harvard Bioscience HBIO
NASDAQ HBIO
$8.23 -0.11 (-1.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2016 - 2025)

Updated

Harvard Bioscience's Asset Writedowns and Impairment was $47.95 million in FY2025.

Analysis

Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2016 - 2025) Analysis & Trends

  • The FY2025 figure marks the lowest annual Asset Writedowns and Impairment since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Harvard Bioscience 37.45 Mn 8.42 Mn 12.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 48.00 Mn
Dec 31, 2019 99,000.00
Sep 30, 2019 460,000.00
Jun 30, 2019 941,000.00
Sep 30, 2016 676,000.00
API Access

Harvard Bioscience Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=HBIO&period=max&api_key=YOUR_API_KEY